Prasugrel and Acquired Thrombotic Thrombocytopenic Purpura Associated with ADAMTS13 Activity Deficiency
We report a case of a 64-year-old male who, 44 days after starting treatment with prasugrel, presented with severe thrombocytopenia, anemia, renal failure, and severe ADAMTS13 activity deficiency, along with a high titer of autoantibodies to this protease.
Main Authors: | Yanet Parodis Lopez, Nery Sablon Gonzalez, Noel Lorenzo Villalba, Rafael Camacho Galvan, Jose Carlos Rodriguez Perez |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2016-07-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | http://ejcrim.com/index.php/EJCRIM/article/view/446 |
Similar Items
-
Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study
by: Wolfgang Miesbach, et al.
Published: (2019-11-01) -
Adenocarcinoma of the lung presenting as thrombotic thrombocytopenic purpura
by: Ahmed Dirweesh, et al.
Published: (2017-01-01) -
An insidious presentation of thrombotic thrombocytopenic purpura: A case report and brief literature review
by: Shafeek Kiblawi, et al.
Published: (2014-01-01) -
Thrombotic thrombocytopenic purpura (TTP) or Moschowitz syndrome: a true hematologic emergency
by: Deborah Melis, et al.
Published: (2012-01-01) -
Relapsing thrombotic thrombocytopenic purpura with low ADAMTS13 antigen levels: An indication for splenectomy?
by: Anna Maria Lombardi, et al.
Published: (2019-03-01)